Update Status of the BRITE Database


IDBrite hierarchyLast update
00001KEGG Orthology (KO)11-12-15
00002KEGG pathway modules11-12-13
00194Photosynthesis proteins10-12-20
00199Cytochrome P45011-11-15
00535Proteoglycans06-3-10
01000Enzymes11-12-16
01001Protein kinases11-10-19
01002Peptidases11-8-22
01003Glycosyltransferases11-10-21
01004Lipid biosynthesis proteins11-5-16
01005Lipopolysaccharide biosynthesis proteins09-12-25
01006Prenyltransferases10-10-25
01007Amino acid related enzymes11-12-2
01008Polyketide biosynthesis proteins11-12-1
01020Enzyme-linked receptors10-8-28
02000Transporters11-12-14
02001Solute carrier family11-11-24
02022Two-component system10-7-6
02035Bacterial motility proteins10-7-6
02042Bacterial toxins11-11-15
02044Secretion system11-10-4
03000Transcription factors11-12-13
03009Ribosome biogenesis11-11-15
03011Ribosome11-5-9
03012Translation factors11-8-10
03016Transfer RNA biogenesis11-10-13
03021Transcription machinery11-12-6
03032DNA replication proteins11-6-24
03036Chromosome11-10-24
03041Spliceosome11-8-9
03051Proteasome10-4-14
03110Chaperones and folding catalysts11-3-31
03310Nuclear receptors10-8-31
03400DNA repair and recombination proteins11-12-6
04030G protein-coupled receptors11-7-27
04031GTP-binding proteins10-8-17
04040Ion channels11-11-24
04050Cytokine receptors10-9-5
04052Cytokines11-3-8
04090Cellular antigens10-9-30
04091Glycan binding proteins10-1-25
04121Ubiquitin system11-12-5
04131SNAREs10-6-22
04515Cell adhesion molecules (CAMs)10-10-21
04516CAM ligands10-10-19
04812Cytoskeleton proteins09-10-15
08001Compounds with biological roles11-12-8
08002Lipids11-10-11
08003Phytochemical compounds11-9-1
08005Bioactive peptides10-9-13
08006Endocrine disrupting compounds10-11-17
08007Pesticides11-4-6
08008Carcinogens11-6-6
08201Enzymatic reactions11-12-14
08202IUBMB reaction hierarchy11-11-29
08203Glycosyltransferase reactions09-10-6
08204Reaction class11-12-16
08301Therapeutic category of drugs in Japan11-11-29
08301_enzymeTherapeutic category of drugs in Japan + Enzyme11-11-29
08301_targetTherapeutic category of drugs in Japan + Target11-11-29
08302USP drug classification11-1-6
08302_enzymeUSP drug classification + Enzyme11-1-6
08302_targetUSP drug classification + Target11-1-6
08303Anatomical Therapeutic Chemical (ATC) classification11-12-1
08303_enzymeAnatomical Therapeutic Chemical (ATC) classification + Enzyme11-12-1
08303_targetAnatomical Therapeutic Chemical (ATC) classification + Target11-12-1
08304Traditional Chinese Medicine in Japan10-7-1
08305Crude drugs11-4-8
08306Phytochemicals used as drugs09-4-20
08307Antiinfectives11-12-1
08308Antineoplastics10-12-8
08310Target-based classification of drugs11-9-2
08311Drugs listed in the Japanese Pharmacopoeia11-4-25
08312Risk category of Japanese OTC drugs11-11-17
08313Classification of Japanese OTC drugs11-3-31
08321Essential oils10-7-23
08322Medicinal herbs10-12-9
08331Animal drugs in Japan11-2-14
08401Infectious diseases11-9-21
08401_genomeInfectious diseases + Genome11-9-21
08402Human diseases11-12-9
08402_geneHuman diseases + Gene11-12-9
08403ICD-10 disease classification11-9-21
08410ICD-10 International Classification of Diseases11-6-6
08420ICD-O-3 International Classification of Diseases for Oncology11-7-20
08430Medical dictionary for regulatory activities (MedDRA)11-10-11
08501Human organ systems11-12-2
08502Human cells11-8-3
08601KEGG organisms11-12-15
08602Animal classification11-9-9
08603Plant classification11-6-14
08604Photosynthetic organisms10-8-22
08901KEGG pathway maps11-11-24
08902BRITE functional hierarchies11-12-12


Last updated: December 16, 2011
Back to KEGG table of contents